ESCRS - PO386 - Preliminary Outcomes With A Phase-Ring Based Enhanced Monofocal Iol

Preliminary Outcomes With A Phase-Ring Based Enhanced Monofocal Iol

Published 2025 - 43rd Congress of the ESCRS

Reference: PO386 | Type: Free paper | DOI: 10.82333/nhyf-m777

Authors: Francesco Blasetti* 1 , Anna Rodella 1 , Franco Spedale 1

1Ophthalmology,Asst-Franciacorta,Chiari,Italy

Purpose

Purpose: To evaluate the clinical performance of the Asqelio™ Pluris™ intraocular lens (IOL), an enhanced monofocal IOL featuring Phase-Ring technology, three months after bilateral implantation in patients undergoing cataract surgery or refractive lens exchange.

Setting

Settings: Clínica IOA Miranza, Madrid, and Clinica Visióon, Granada (Spain)

Methods

Patients and Methods: This prospective, observational, post-marketing pilot study included 30 patients bilaterally implanted with Asqelio™ Pluris™. The study assessed monocular and binocular visual acuity (distance, intermediate, and near), defocus curves, ocular aberrometry, and patient-reported outcomes. Data collection was performed at a single postoperative visit, three months after implantation.

Results

Results: Preliminary analysis suggests that the Asqelio™ Pluris™ IOL provides enhanced intermediate visual acuity compared to conventional monofocal IOLs, as indicated by defocus curve measurements. The Phase-Ring technology contributes to improve through-focus performance, reducing patient dependence on additional optical correction for mid-range tasks. Ocular aberrometry indicated low residual higher-order aberrations. Patient reported questionnaire scores reflected a high level of visual quality with minimal photic disturbances.

Conclusions

Conclusions: The Asqelio™ Pluris™ IOL offers superior intermediate visual performance while maintaining distance visual acuity comparable to standard monofocal lenses. Its Phase-Ring design enhances optical quality without introducing significant visual side effects. These findings support its potential as an effective alternative for patients seeking improved functional vision across various distances post-cataract surgery.